158 related articles for article (PubMed ID: 37932728)
1. Usability of serum hedgehog signalling proteins as biomarkers in canine mammary carcinomas.
Koo H; Lee S; Kim WH
BMC Vet Res; 2023 Nov; 19(1):231. PubMed ID: 37932728
[TBL] [Abstract][Full Text] [Related]
2. Detection of neurokinin-1 receptor by immunohistochemistry in canine mammary gland tumours.
Song D; Oh YI; Kim JM; Cheon DS; Kim DY; Seo KW
Vet Med Sci; 2020 Nov; 6(4):958-964. PubMed ID: 32657032
[TBL] [Abstract][Full Text] [Related]
3. Markers of lipid peroxidation and α-tocopherol levels in the blood and neoplastic tissue of dogs with malignant mammary gland tumors.
Karayannopoulou M; Fytianou A; Assaloumidis N; Psalla D; Constantinidis TC; Kaldrymidou E; Koutinas AF
Vet Clin Pathol; 2013 Sep; 42(3):323-8. PubMed ID: 23906434
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of SLUG expression in canine mammary gland tumors and its prognostic significance.
Cheon SB; Kim WH
BMC Vet Res; 2023 Aug; 19(1):112. PubMed ID: 37553661
[TBL] [Abstract][Full Text] [Related]
5. Metastasis prognostic factors and cancer stem cell-related transcription factors associated with metastasis induction in canine metastatic mammary gland tumors.
Kim S; Bok E; Lee S; Lee HJ; Choe Y; Kim NH; Lee WJ; Rho GJ; Lee SL
J Vet Sci; 2021 Sep; 22(5):e62. PubMed ID: 34423600
[TBL] [Abstract][Full Text] [Related]
6. YRNA and tRNA fragments can differentiate benign from malignant canine mammary gland tumors.
Hasan MN; Rahman MM; Husna AA; Nozaki N; Yamato O; Miura N
Biochem Biophys Res Commun; 2024 Jan; 691():149336. PubMed ID: 38039834
[TBL] [Abstract][Full Text] [Related]
7. L-type amino acid transporter 1 (LAT1) expression in canine mammary gland tumors.
Fukumoto S; Hanazono K; Komatsu T; Iwano H; Kadosawa T; Uchide T
J Vet Med Sci; 2013 May; 75(4):431-7. PubMed ID: 23171689
[TBL] [Abstract][Full Text] [Related]
8. Alteration of somatostatin receptor 2 expression in canine mammary gland tumor.
Sakai K; Yonezawa T; Yamawaki H; Oyamada T
J Vet Med Sci; 2015 Oct; 77(10):1319-22. PubMed ID: 25985817
[TBL] [Abstract][Full Text] [Related]
9. Decorin concentrations in canine normal and neoplastic mammary gland tissues.
Szczubiał M; Kankofer M; Wawrzykowski J; Dąbrowski R; Łopuszyński W; Bochniarz M; Brodzki P
Reprod Domest Anim; 2020 Oct; 55(10):1404-1410. PubMed ID: 33470009
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel tumour-associated antigens in canine mammary gland tumour.
Furuya M; Funasaki M; Tani H; Sasai K
Vet Comp Oncol; 2015 Sep; 13(3):194-202. PubMed ID: 23510442
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019.
Srisawat W; Pringproa K; Prachasilchai W; Thongtharb A; Sthitmatee N
PeerJ; 2024; 12():e17077. PubMed ID: 38500523
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic detection of canine mammary gland tumours after oral administration of 5-aminolevulinic acid.
Osaki T; Yokoe I; Ogura S; Takahashi K; Murakami K; Inoue K; Ishizuka M; Tanaka T; Li L; Sugiyama A; Azuma K; Murahata Y; Tsuka T; Ito N; Imagawa T; Okamoto Y
Vet Comp Oncol; 2017 Sep; 15(3):731-739. PubMed ID: 26766288
[TBL] [Abstract][Full Text] [Related]
13. Canine mammary gland disease in New Zealand: a review of samples from 797 dogs.
Ariyarathna H; Aberdein D; Thomson N; Gibson I; Munday JS
N Z Vet J; 2022 Mar; 70(2):95-100. PubMed ID: 34756151
[TBL] [Abstract][Full Text] [Related]
14. Changes in serum neopterin and C-reactive protein concentrations in female dogs with mammary gland tumours.
Szczubiał M; Dabrowski R; Łopuszyński W; Bochniarz M; Krawczyk M
Pol J Vet Sci; 2018 Dec; 21(4):691-696. PubMed ID: 30605283
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of mammary gland tumours in male dogs and its weak association with development of testicular tumours: a review.
Tkaczyk-Wlizło A; Kowal K; Śmiech A; Ślaska B
J Appl Genet; 2024 Feb; 65(1):137-153. PubMed ID: 38123735
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles in canine mammary carcinomas of various grades of malignancy.
Pawłowski KM; Maciejewski H; Dolka I; Mol JA; Motyl T; Król M
BMC Vet Res; 2013 Apr; 9():78. PubMed ID: 23587192
[TBL] [Abstract][Full Text] [Related]
17. The Hedgehog signalling pathway and its prognostic impact in human gliomas.
Li Q; Zhang Y; Zhan H; Yuan Z; Lu P; Zhan L; Xu W
ANZ J Surg; 2011 Jun; 81(6):440-5. PubMed ID: 22295347
[TBL] [Abstract][Full Text] [Related]
18. Establishment of canine mammary gland tumor cell lines harboring PI3K/Akt activation as a therapeutic target.
Park SY; Baek YB; Lee CH; Kim HJ; Kim HP; Jeon YJ; Song JE; Jung SB; Kim HJ; Moon KS; Park SI; Lee CM; Kim SH
BMC Vet Res; 2024 May; 20(1):233. PubMed ID: 38807154
[TBL] [Abstract][Full Text] [Related]
19. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
20. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer.
Klopfleisch R; Hvid H; Klose P; da Costa A; Gruber AD
Vet Comp Oncol; 2010 Dec; 8(4):293-301. PubMed ID: 21062411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
